C29H31ClFNO11
Neat
624.01
Room Temperature
Elvitegravir acyl glucuronide; Elvitegravir (m4); 870649-25-5; UNII-F7LG22FZCH; F7LG22FZCH; (2S, 3S, 4S, 5R, 6S)-6-[6-[(3-chloro-2-fluorophenyl)methyl]-1-[(2S)-1-hydroxy-3-methylbutan-2-yl]-7-methoxy-4-oxoquinoline-3-carbonyl]oxy-3, 4, 5-trihydroxyoxane-2-carboxylic acid; beta-D-Glucopyranuronic acid, 1-(6-((3-chloro-2-fluorophenyl)methyl)-1, 4-dihydro-1-((1S)-1-(hydroxymethyl)-2-methylpropyl)-7-methoxy-4-oxo-3-quinolinecarboxylate); SCHEMBL4364786; Elvitegravir-acyl-glucuronide (M4); Q27277774; (2S, 3S, 4S, 5R, 6S)-6-((6-(3-Chloro-2-fluorobenzyl)-1-((S)-1-hydroxy-3-methylbutan-2-yl)-7-methoxy-4-oxo-1, 4-dihydroquinoline-3-carbonyl)oxy)-3, 4, 5-trihydroxytetrahydro-2H-pyran-2-carboxylic acid; .BETA.-D-GLUCOPYRANURONIC ACID, 1-(6-((3-CHLORO-2-FLUOROPHENYL)METHYL)-1, 4-DIHYDRO-1-((1S)-1-(HYDROXYMETHYL)-2-METHYLPROPYL)-7-METHOXY-4-OXO-3-QUINOLINECARBOXYLATE); beta-D-Glucopyranuronic Acid 1-[6-[(3-Chloro-2-fluorophenyl)methyl]-1, 4-dihydro-1-[(1S)-1-(hydroxymethyl)-2-methylpropyl]-7-methoxy-4-oxo-3-quinolinecarboxylate]; Elvitegravir Acyl Glucuronide; ss-D-Glucopyranuronic acid, 1-[6-[(3-chloro-2-fluorophenyl)methyl]-1 and 4-dihydro-1-[(1S)-1-(hydroxymethyl)-2-methylpropyl]-7-methoxy-4-oxo-3-quinolinecarboxylate]
(2S, 3S, 4S, 5R, 6S)-6-[6-[(3-chloro-2-fluorophenyl)methyl]-1-[(2S)-1-hydroxy-3-methylbutan-2-yl]-7-methoxy-4-oxoquinoline-3-carbonyl]oxy-3, 4 and 5-trihydroxyoxane-2-carboxylic acid
InChI=1S/C29H31ClFNO11/c1-12(2)19(11-33)32-10-16(28(40)43-29-25(37)23(35)24(36)26(42-29)27(38)39)22(34)15-8-14(20(41-3)9-18(15)32)7-13-5-4-6-17(30)21(13)31/h4-6,8-10,12,19,23-26,29,33,35-37H,7,11H2,1-3H3,(H,38,39)/t19-,23+,24+,25-,26+,29+/m1/s1